Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative fluid management in cadaveric renal transplantation: normal saline versus balanced infusates
2009-018050-34Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Elo-Mel Isoton and sodium chloride in end-stage kidney disease (ESKD) (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Intraoperative and postoperative hyperkalemia and Need for postoperative dialysis. Started May 2010; status: completed.
02
Drugs
Elo-Mel Isotonsodium chloride
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2009-018050-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018050-34.